Pall Corporation manufactures and markets filtration, separation, and purification products; and integrated systems solutions worldwide. Its Life Sciences segment provides technologies that facilitate the process of drug discovery, development, regulatory validation, and production, which are used in the research laboratories, pharmaceutical, biotechnology, and food and beverage industries, as well as in hospitals. It offers medical products to control the spread of infections in hospitals; cell therapy products; and filtration and purification technologies, associated hardware, and engineered systems for the development and commercialization of drugs, plasma, and vaccines. This segment also provides validation services to drug manufacturers; offers laboratory products for use in drug research and discovery, quality control testing, and environmental monitoring applications; and serves the filtration needs of beer, wine, dairy, alcohol-free beverage, bottled water, and food ingredient markets. This segment sells products through its direct sales force and distributors. The company’s Industrial segment provides various technologies to producers and users of energy, oil, gas, renewable and alternative fuels, power, chemicals, and water, as well as to the machinery and equipment markets. This segment also offers filtration and fluid monitoring equipment for use in commercial and military aircraft, and marine and land-based military vehicles; filtration and purification technologies for the semiconductor, data storage, graphic arts, display, and electronic components markets; and a suite of contamination control solutions for chemical, gas, water, chemical mechanical polishing, and photolithography processes. Pall Corporation has a strategic collaboration agreement with Artesyn Biosolutions. The company was founded in 1946 and is headquartered in Port Washington, New York. Pall Corporation operates as a subsidiary of Danaher Corporation.